<< Pfizer Inc. said it has begun human safety testing of a new pill to treat the coronavirus that could be used at the first sign of illness. If it succeeds in trials, the pill could be prescribed early in an infection to block viral replication before patients get very sick. The drug binds to an enzyme called a protease (Pfizer’s oral protease inhibitor, code-named PF-07321332,) to keep the virus from replicating. >>
<< In lab tests, it worked against many coronaviruses, including the original SARS virus and MERS. Additionally, the coronavirus protease doesn’t mutate much, which means the therapy is likely to work equally well against numerous variant strains, >>
️
<< This is really a potential game changer, >>️ Mikael Dolsten️
Robert Langreth. Pfizer Begins Human Trials of New Pill to Treat Coronavirus.
Mar 23, 2021 17:38 CET.
Christie Aschwanden. Five reasons why COVID herd immunity is probably impossible. Nature 591, 520-522. doi: 10.1038/ d41586-021-00728-2. Mar 18, 2021.
Angela L. Rasmussen, Saskia V. Popescu. SARS-CoV-2 transmission without symptoms. Science, 2021; 371 (6535): 1206-1207 doi: 10.1126/ science.abf9569
Also
keyword 'virus' in FonT:
keyword 'virus' in Notes (quasi-stochastic poetry):